Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

ACRUX LIMITED

INVESTOR PRESENTATION - ACRUX LIMITED

ASX:ACR

ACRUX LIMITED

Health Care

Acrux Limited (ACR) is an Australian drug delivery company, who is developing and commercialising pharmaceutical products for global markets. ACR uses innovative technology to administer medicines through the skin. ACR conducts its operations in Australia, Switzerland, USA and overseas, with three marketed products including AXIRON, Evamist and Recuvyra. Former Names --

Read more

Market Cap

$31.56m

Price at Close

$0.187

4w avg. Volume

109.20k

4w avg. Turnover

$18.72k

Announcements
announcementt+2 movementdate
  • Change of Director's Interest Notice

    Shareholder Details

  • 0.00%

    17 Nov 2020

0.00%

17 Nov 2020
  • Appendix 3G

    Issued Capital

  • 0.00%

    17 Nov 2020

0.00%

17 Nov 2020
  • Results of Annual General Meeting

    Notice Of Meeting

  • 0.00%

    12 Nov 2020

0.00%

12 Nov 2020
  • Annual General Meeting Script

    Chairman's Address

  • +2.94%

    11 Nov 2020

+2.94%

11 Nov 2020
  • Annual General Meeting Presentation

    Chairman's Address

  • +2.94%

    11 Nov 2020

+2.94%

11 Nov 2020
  • Receipt of R&D Tax Incentive Rebate - Acrux Commercial

    Periodic Reports

  • -2.86%

    27 Oct 2020

-2.86%

27 Oct 2020
  • Receipt of R&D Tax Incentive Rebate - Acrux Pharma Pty Ltd

    Periodic Reports

  • +5.56%

    14 Oct 2020

+5.56%

14 Oct 2020
  • Acrux Signs Licensing Agreement with Dash Pharmaceuticals

    Progress Report · Market sensitive

  • -2.70%

    11 Oct 2020

-2.70%

11 Oct 2020
  • AGM - Virtual Meeting Online Guide

    Notice Of Meeting

  • +5.71%

    05 Oct 2020

+5.71%

05 Oct 2020
  • Notice of Annual General Meeting and Proxy Form

    Notice Of Meeting

  • +5.71%

    05 Oct 2020

+5.71%

05 Oct 2020
Market Data

Current Price

$0.187

52WK HIGH

$0.22

52WK LOW

$0.105

1YR RETURN

+1.08%

1YR RETURN VS. SECTOR

-1825.65%

90 DAY RETURN

+1.08%

ASX RANK

1,293

/2,024

SECTOR RANK

24

/32

SHARES OUTSTANDING

168.75m
ASX:ACR

ACRUX LIMITED

Health Care

Acrux Limited (ACR) is an Australian drug delivery company, who is developing and commercialising pharmaceutical products for global markets. ACR uses innovative technology to administer medicines through the skin. ACR conducts its operations in Australia, Switzerland, USA and overseas, with three marketed products including AXIRON, Evamist and Recuvyra. Former Names --

Read more

Market Cap

$31.56m

Price at Close

$0.187

4w avg. Volume

109.20k

4w avg. Turnover

$18.72k

ASX:ACR is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.